Beginning Cash: The amount of cash reported by the company on its previous statement.
Phio Pharmaceuticals Corp. (PHIO) had Beginning Cash of $21.03M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-4.00M |
|
-- |
|
-- |
|
$4.17M |
|
$-4.17M |
|
$0.16M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.17M |
|
$-4.17M |
|
11.62M |
|
11.62M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$17.40M |
|
$0.01M |
|
$0.01M |
|
$17.41M |
|
$0.95M |
|
-- |
|
-- |
|
$0.95M |
|
$16.46M |
|
$16.46M |
|
$16.46M |
|
11.62M |
|
| Cash Flow Statement Financials | |
$-4.00M |
|
$0.00M |
|
-- |
|
|
Beginning Cash |
$21.03M |
$17.03M |
|
$-4.00M |
|
$0.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.32% |
|
-24.32% |
|
-22.99% |
|
-24.32% |
|
$1.42 |
|
$-0.34 |
|
$-0.34 |
|